Neurobiological Technologies Price Prediction
| NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Neurobiological Technologies hype-based prediction, you can estimate the value of Neurobiological Technologies from the perspective of Neurobiological Technologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Neurobiological Technologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Neurobiological because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Neurobiological Technologies after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neurobiological |
Neurobiological Technologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Neurobiological Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neurobiological Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neurobiological Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neurobiological Technologies Estimiated After-Hype Price Volatility
In the context of predicting Neurobiological Technologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neurobiological Technologies' historical news coverage. Neurobiological Technologies' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Neurobiological Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neurobiological Technologies is very steady at this time. Analysis and calculation of next after-hype price of Neurobiological Technologies is based on 3 months time horizon.
Neurobiological Technologies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Neurobiological Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neurobiological Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neurobiological Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 0 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 0.00 |
|
Neurobiological Technologies Hype Timeline
Neurobiological Technologies is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neurobiological is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Neurobiological Technologies is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neurobiological Technologies last dividend was issued on the 27th of December 2012. The entity had 1:7 split on the 17th of September 2007. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.Neurobiological Technologies Related Hype Analysis
Having access to credible news sources related to Neurobiological Technologies' direct competition is more important than ever and may enhance your ability to predict Neurobiological Technologies' future price movements. Getting to know how Neurobiological Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neurobiological Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PHGUF | Pharming Group NV | 0.00 | 0 per month | 0.00 | (0.11) | 0.00 | 0.00 | 17.81 | |
| KNBIF | Kane Biotech | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | (2.81) | 29.80 | |
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MMIRF | MedMira | 0.00 | 0 per month | 0.00 | 0.12 | 0.77 | (0.17) | 321.49 | |
| OCTHF | Oxford Cannabinoid Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neurobiological Technologies Additional Predictive Modules
Most predictive techniques to examine Neurobiological price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurobiological using various technical indicators. When you analyze Neurobiological charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neurobiological Technologies Predictive Indicators
The successful prediction of Neurobiological Technologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neurobiological Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neurobiological Technologies based on analysis of Neurobiological Technologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neurobiological Technologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neurobiological Technologies's related companies.
Story Coverage note for Neurobiological Technologies
The number of cover stories for Neurobiological Technologies depends on current market conditions and Neurobiological Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neurobiological Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neurobiological Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Neurobiological Technologies Short Properties
Neurobiological Technologies' future price predictability will typically decrease when Neurobiological Technologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neurobiological Technologies often depends not only on the future outlook of the potential Neurobiological Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neurobiological Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Dividends Paid | 25.1 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets |